Cooperative Agreement U2GGH001650

The federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) provides $8,536,000 in funding to the African Field Epidemiology Network Ltd. (AFENET) to implement the "REINFORCING IMMUNIZATION SYSTEMS FOR CONSEQUENTIAL GEOGRAPHIES (RISE4CGS) IN DRC, ETHIOPIA AND NIGERIA" project. This 5-year cooperative agreement, which commenced on September 30, 2024, aims to strengthen...

The United States Agency for International Development (USAID) Bureau for Global Health awarded a cooperative agreement totaling $78,980,821 to DAI Global LLC, doing business as DAI, to improve the capacity of countries in high-risk areas to respond to outbreaks of emergent zoonotic diseases in Uganda. The purpose of this agreement was to enhance Uganda's ability to detect and respond to zoonotic disease outbreaks from 2009 to 2014 through USAID's Foreign Assistance for Programs Overseas...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $6,749,031 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Association de Sante Familiale (ASF), a local nonprofit organization, and PATH, a U.S.-based international NGO, for the "USHINDI Project" in the Democratic Republic of the Congo (DRC). The project aims to enhance access to comprehensive HIV services and achieve epidemic control in seven health zones in Haut-Katanga province. Key...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) provides $820,000.00 in funding to World Vision Inc. for the "STRENGTHENING ROUTINE IMMUNIZATION AND VACCINE EQUITY (STRIVE) IN THE DEMOCRATIC REPUBLIC OF THE CONGO AND BRAZIL" project. The award period runs from Sep 30, 2024 to Sep 29, 2029. The project aims to strengthen routine immunization and improve vaccine equity in the...

This $532,978 Cooperative Agreement award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to identify the placental cell types and mechanisms involved in Ebola virus (EBOV) transmission from mother to fetus during pregnancy. The research aims to define the tropism of EBOV within placental tissues in early and late pregnancy, and investigate the role of phosphatidylserine...

This Cooperative Agreement award, funded by the Centers for Disease Control and Prevention under the Global AIDS program (CFDA 93.067), supports the Global Health Systems Solutions (GHSS) organization in building and improving integrated laboratory capacity and quality services in the Democratic Republic of the Congo (DRC) under the President's Emergency Plan for AIDS Relief (PEPFAR). Specifically, the $11,097,080 award will enable GHSS to: 1) scale up quality assurance and improvement for HIV...

This $2,777,976 Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program, aims to improve the response to HIV and ensure sustained epidemic control in targeted areas of the Democratic Republic of Congo (DRC). The primary awardee, Family Health International (FHI 360), will implement activities to decrease new HIV infections and reduce HIV-associated morbidity and mortality in the...

This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $6,960,000 Cooperative Agreement under the Global AIDS (CFDA 93.067) program to the Crihss Foundation in Cameroon. The 5-year INTRASSAT project, starting September 2024, aims to establish an integrated and sustainable sample transport system to improve the integrity and efficiency of diagnostic sample referral and transportation in Cameroon. The project will streamline fragmented sample transportation systems into a cohesive...

This Project Grant award of $160,000 from the Department of State Bureau of African Affairs supports efforts by Adpp Angola under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029) to prevent mother-to-child transmission of HIV in Angola. Key deliverables include strengthening HIV care and treatment at health facilities, increasing community engagement, and building clinical laboratory and supply chain infrastructure from August 6, 2021 to September 30, 2021....